NTRA
Natera, Inc. · Healthcare · Medical - Diagnostics & Research
Input momentum (manajer yang sebanding):
keluasan pemegang -4.8% ·
aliran saham +1.9% ·
posisi baru bersih -5.0%
· formula
Akumulasi terkonsentrasi: saham yang meningkat di antara lebih sedikit pemegang
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q2 2025
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 215.03K | $85.48M | n/a | −3 |
| Q2 2026 | 160 | 0 | 103.68M | $28.12B | +5 | −6 |
| Q1 2026 | 164 | +3 | 98.65M | $19.54B | +6 | −4 |
| Q4 2025 | 160 | 0 | 102.31M | $23.44B | +1 | n/a |
| Q3 2025 | 23 | +1 | 81.70M | $13.15B | +1 | −1 |
| Q2 2025 | 20 | -1 | 57.32M | $9.68B | n/a | −1 |
| Q1 2025 | 18 | 0 | 31.15M | $4.40B | n/a | n/a |
| Q4 2024 | 18 | 0 | 26.97M | $4.27B | n/a | n/a |
| Q3 2024 | 17 | -1 | 21.42M | $2.72B | n/a | −1 |
| Q2 2024 | 18 | n/a | 16.29M | $1.76B | n/a | n/a |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (pasif) | 12.68M | n/a | $2.14B | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 2 | T. Rowe Price ✦ | 12.19M | +15.7% | $2.06B | 0.2% | ▲ Add | 5 | SEC ↗ ×2 |
| 3 | BlackRock ✦ (pasif) | 10.96M | n/a | $1.85B | 0.0% | n/c | 1 | SEC ↗ ×22 |
| 4 | State Street Global Advisors ✦ (pasif) | 3.32M | -1.6% | $560.46M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | Duquesne Family Office ✦ | 3.09M | -9.3% | $521.21M | 13.3% | ▼ Trim | 5 | SEC ↗ |
| 6 | Wellington Management ✦ | 2.63M | -13.9% | $444.94M | 0.1% | ▼ Trim | 5 | SEC ↗ ×4 |
| 7 | Geode Capital Management ✦ (pasif) | 2.55M | +7.0% | $430.64M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 8 | AQR Capital Management ✦ | 1.73M | +44.6% | $291.72M | 0.2% | ▲ Add | 5 | SEC ↗ ×6 |
| 9 | Norges Bank ✦ (pasif) | 1.64M | +14.8% | $277.75M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 10 | Fidelity (FMR) ✦ | 1.45M | n/a | $245.41M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 11 | Capital World Investors ✦ | 1.41M | +255.6% | $238.15M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 12 | ARK Investment Management ✦ | 936.39K | -0.7% | $158.19M | 1.2% | ▼ Trim | 5 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 821.45K | -61.3% | $138.77M | 0.1% | ▼ Trim | 5 | SEC ↗ ×2 |
| 14 | Renaissance Technologies ✦ | 493.80K | +42.0% | $83.42M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 15 | Arrowstreet Capital ✦ | 483.24K | +29.3% | $81.64M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 16 | Two Sigma Investments ✦ | 252.44K | +230.2% | $42.65M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 17 | Point72 Asset Management ✦ | 235.00K | -62.4% | $39.70M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 18 | Millennium Management ✦ | 176.51K | -31.0% | $29.82M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 19 | D. E. Shaw & Co. ✦ | 173.80K | -28.5% | $29.36M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 20 | Gotham Asset Management ✦ | 101.61K | -11.3% | $17.17M | 0.1% | ▼ Trim | 5 | SEC ↗ |
"Their weight" = porsi posisi dari nilai ekuitas 13F yang dilaporkan manajer tersebut: ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Tidak ada pembeli terlacak baru kuartal ini. |
Telah keluar
| Marshall Wace | $37.41M | adalah 0.1% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 755 pemegang, 120.14M saham, $20.15B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang sekuritas ini yang dilacak: jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Director · 627 lbr · $257,003
Director · 605 lbr · $248,847
Director · 962 lbr · $392,745
Director · 125 lbr · $51,631
Director · 211 lbr · $86,974
Director · 255 lbr · $105,995
Director · 165 lbr · $68,751
Director · 200 lbr · $81,300
Director · 80 lbr · $32,484
Director · 50 lbr · $20,258
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi